NCT00948168 Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00944450 Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027) Status COMPLETED Phase PHASE1
NCT00943371 A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002) Status TERMINATED Phase PHASE1
NCT00942318 Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00941161 Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00935532 Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00935467 Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00931034 Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women Status COMPLETED Phase NA
NCT00930865 Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00924573 Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride Status COMPLETED Phase PHASE3
NCT00924105 Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT00923962 Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT00917267 A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects Status COMPLETED Phase PHASE3
NCT00915954 Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT) Status COMPLETED Phase NA
NCT00913393 Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy Status TERMINATED Phase PHASE2
NCT00913367 Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4